NVO chart by timeframe
Trendlines, support and resistance and patterns come from the newest signal of the selected timeframe.
No signal on this timeframe — price and EMA only.
Both worlds over time
Technical and news signals of the last 90 days on one timeline.
What is being reported about NVO
📝 Overview Generated automatically?
NVO has been the subject of 10 signals across 10 articles in the last 365 days. Sentiment skews Bullish (60%).
Breakdown: 6 bullish, 4 bearish, 0 neutral. AI confidence averages 79% across all signals.
Most-cited catalysts: EMA CHMP positive opinion on Wegovy oral (1×), Potential European Commission approval within months (1×), Danish Economy Ministry upgraded GDP forecast, crediting pharmaceutical sector. (1×). Most-cited risk factors: Competition from Eli Lilly's orforglipron progressing in trials (1×), Pricing and reimbursement challenges in European markets (1×), Regulatory clampdown on high drug prices in the US or EU could cut margins. (1×).
Related assets
Same category or comparable signal picture — each card opens the full cockpit.